These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30530211)

  • 1. A Single H1 Promoter Can Drive Both Guide RNA and Endonuclease Expression in the CRISPR-Cas9 System.
    Gao Z; Herrera-Carrillo E; Berkhout B
    Mol Ther Nucleic Acids; 2019 Mar; 14():32-40. PubMed ID: 30530211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 3. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a mono-promoter-driven CRISPR/Cas9 system in mammalian cells.
    Yoshioka S; Fujii W; Ogawa T; Sugiura K; Naito K
    Sci Rep; 2015 Dec; 5():18341. PubMed ID: 26669567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Development of a Viral Mediated CRISPR/Cas9 System with Doxycycline Dependent gRNA Expression for Inducible In vitro and In vivo Genome Editing.
    de Solis CA; Ho A; Holehonnur R; Ploski JE
    Front Mol Neurosci; 2016; 9():70. PubMed ID: 27587996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Mini' U6 Pol III promoter exhibits nucleosome redundancy and supports multiplexed coupling of CRISPR/Cas9 effects.
    Preece R; Georgiadis C; Gkazi SA; Etuk A; Christi A; Qasim W
    Gene Ther; 2020 Sep; 27(9):451-458. PubMed ID: 32203198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing.
    Ortinski PI; O'Donovan B; Dong X; Kantor B
    Mol Ther Methods Clin Dev; 2017 Jun; 5():153-164. PubMed ID: 28497073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease.
    Uchida N; Drysdale CM; Nassehi T; Gamer J; Yapundich M; DiNicola J; Shibata Y; Hinds M; Gudmundsdottir B; Haro-Mora JJ; Demirci S; Tisdale JF
    Mol Ther Methods Clin Dev; 2021 Jun; 21():121-132. PubMed ID: 33816645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9; A robust technology for producing genetically engineered plants.
    Farooq R; Hussain K; Nazir S; Javed MR; Masood N
    Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):31-38. PubMed ID: 30511631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intron-Based Single Transcript Unit CRISPR Systems for Plant Genome Editing.
    Zhong Z; Liu S; Liu X; Liu B; Tang X; Ren Q; Zhou J; Zheng X; Qi Y; Zhang Y
    Rice (N Y); 2020 Feb; 13(1):8. PubMed ID: 32016614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized CRISPR-Cas9 Genome Editing for
    Zhang WW; Lypaczewski P; Matlashewski G
    mSphere; 2017; 2(1):. PubMed ID: 28124028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
    Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
    Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures.
    Ophinni Y; Inoue M; Kotaki T; Kameoka M
    Sci Rep; 2018 May; 8(1):7784. PubMed ID: 29773895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a One-Vector Multiplex CRISPR/Cas9 Editing System to Inhibit Nucleopolyhedrovirus Replication in Silkworms.
    Dong Z; Qin Q; Hu Z; Chen P; Huang L; Zhang X; Tian T; Lu C; Pan M
    Virol Sin; 2019 Aug; 34(4):444-453. PubMed ID: 31218589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing a dual knock-out cell line by lentivirus based combined CRISPR/Cas9 and Loxp/Cre system.
    Li Y; Zhang W; Zhao J; Li S; Shan L; Zhu J; Li Y; Zhu H; Mao Q; Xia H
    Cytotechnology; 2018 Dec; 70(6):1595-1605. PubMed ID: 30173403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient Multiplex Genome Editing Induces Precise, and Self-Ligated Type Mutations in Tomato Plants.
    Hashimoto R; Ueta R; Abe C; Osakabe Y; Osakabe K
    Front Plant Sci; 2018; 9():916. PubMed ID: 30018630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Genome Editing Using CRISPR/Cas9.
    Ding Y; Li H; Chen LL; Xie K
    Front Plant Sci; 2016; 7():703. PubMed ID: 27252719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered miniature H1 promoters with dedicated RNA polymerase II or III activity.
    Gao Z; van der Velden YU; Fan M; van der Linden CA; Vink M; Herrera-Carrillo E; Berkhout B
    J Biol Chem; 2021; 296():100026. PubMed ID: 33154168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulating plant RNA-silencing pathways to improve the gene editing efficiency of CRISPR/Cas9 systems.
    Mao Y; Yang X; Zhou Y; Zhang Z; Botella JR; Zhu JK
    Genome Biol; 2018 Sep; 19(1):149. PubMed ID: 30266091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.